SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells

FEBS Journal

Volumn 281, Issue 21, 2014, Pages 4815-4829

  Zhang, Wenling ^a   Zeng, Zhaoyang ^a   Wei, Fang ^a   Chen, Pan ^a   Schmitt, David C ^b   Fan, Songqing ^c   Guo, Xiaofang ^a   Liang, Fang ^a   Shi, Lei ^c   Liu, Zixin ^b   Zhang, Zuping ^a   Xiang, Bo ^a   Zhou, Ming ^a   Huang, Donghai ^d   Tang, Ke ^a   Li, Xiaoling ^a   Xiong, Wei ^a   Tan, Ming ^b   Li, Guiyuan ^a   Li, Xiayu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Differentiation; Nasopharyngeal carcinoma; Prognosis; SPLUNC1

Indexed keywords

COMPLEMENTARY DNA; HETERODIMER; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; 5' UNTRANSLATED REGION; BPIFA1 PROTEIN, HUMAN; GLYCOPROTEIN; HYBRID PROTEIN; PHOSPHOPROTEIN; SMALL INTERFERING RNA; TUMOR PROTEIN;

ADULT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BINDING SITE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER INHIBITION; CANCER PROGNOSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DNA MICROARRAY; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROMOTER REGION; PROTEIN EXPRESSION; SPLUNC1 GENE; TRANSCRIPTION REGULATION; UPREGULATION; 5' UNTRANSLATED REGION; ADOLESCENT; AGED; BIOSYNTHESIS; CARCINOMA; CELL CYCLE; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL LINE; YOUNG ADULT;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; BINDING SITES; CARCINOMA; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; RETINOID X RECEPTORS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRETINOIN; YOUNG ADULT;

EID: 84915821728     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13020     Document Type: Article

References (48)

1. Bingle CD & Bingle L (2000) Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim Biophys Acta 1493, 363-367.
2. Bingle CD & Craven CJ (2002) PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet 11, 937-943.
3. Bingle CD & Craven CJ (2003) Comparative analysis of the PLUNC (palate, lung and nasal epithelium clone) protein families. Biochem Soc Trans 31, 806-809.
4. Bingle L & Bingle CD (2011) Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. Biochem Soc Trans 39, 1023-1027.
5. Di YP (2011) Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteria. Biochem Soc Trans 39, 1051-1055.
6. Musa M, Wilson K, Sun L, Mulay A, Bingle L, Marriott HM, LeClair EE & Bingle CD (2012) Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1) in the nasal and oral cavities of mice. Cell Tissue Res 350, 455-464.
7. Sayeed S, Nistico L, St Croix C & Di YP (2013) Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection. Infect Immun 81, 285-291.
8. Seshadri S, Lin DC, Rosati M, Carter RG, Norton JE, Suh L, Kato A, Chandra RK, Harris KE, Chu HW et al. (2012) Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis. Allergy 67, 920-928.
9. Zhang B, Nie X, Xiao B, Xiang J, Shen S, Gong J, Zhou M, Zhu S, Zhou J, Qian J et al. (2003) Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosom Cancer 38, 80-90.
10. Zhou HD, Fan SQ, Zhao J, Huang DH, Zhou M, Liu HY, Zeng ZY, Yang YX, Huang H, Li XL et al. (2006) Tissue distribution of the secretory protein, SPLUNC1, in the human fetus. Histochem Cell Biol 125, 315-324.
11. Chen P, Guo X, Zhou H, Zhang W, Zeng Z, Liao Q, Li X, Xiang B, Yang J, Ma J et al. (2013) SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1. PLoS One 8, e56929.
12. Zhou HD, Li XL, Li GY, Zhou M, Liu HY, Yang YX, Deng T, Ma J & Sheng SR (2008) Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus. Mol Cell Biochem 309, 191-197.
13. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL & Zhao J (2006) Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 43, 1864-1871.
14. He Y, Ding YQ, Huang ZX & Yao KT (2007) Association of the coding region single nucleotide polymorphisms in PLUNC gene with nasopharyngeal carcinoma. Zhonghua Yi Xue Za Zhi 87, 1553-1555.
15. Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W, Li X, Fan S, Cao L, Tang K, Wu M et al. (2007) Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol 133, 71-81.
16. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C et al. (2007) Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 38, 120-133.
17. Lee KH, Chang MY, Ahn JI, Yu DH, Jung SS, Choi JH, Noh YH, Lee YS & Ahn MJ (2002) Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem Biophys Res Commun 296, 1125-1133.
18. Yang L, Zhao H, Li SW, Ahrens K, Collins C, Eckenrode S, Ruan QG, McIndoe RA & She JX (2003) Gene expression profiling during all-trans retinoic acidinduced cell differentiation of acute promyelocytic leukemia cells. J Mol Diagn 5, 212-221.
19. Melnick A & Licht JD (1999) Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
20. Freemantle SJ, Spinella MJ & Dmitrovsky E (2003) Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22, 7305-7315.
21. Zhao XH, Zhu HJ, Lu DP & Zhang M (2009) Immunofluorescence examination of CK-13 expression in cell line KB differentiated by all-trans retinoic acid or As2 O3. Zhonghua Kou Qiang Yi Xue Za Zhi 44, 53-55.
22. Carroll JM, Albers KM, Garlick JA, Harrington R & Taichman LB (1993) Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc Natl Acad Sci USA 90, 10270-10274.
23. Casado B, Pannell LK, Iadarola P & Baraniuk JN (2005) Identification of human nasal mucous proteins using proteomics. Proteomics 5, 2949-2959.
24. Ghafouri B, Kihlstrom E, Tagesson C & Lindahl M (2004) PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta 1699, 57-63.
25. Liao Q, Zeng Z, Guo X, Li X, Wei F, Zhang W, Chen P, Liang F, Xiang B, Ma J et al. (2013) LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene 33, 2098-2109.
26. Yang Y, Liao Q, Wei F, Li X, Zhang W, Fan S, Shi L, Gong Z, Ma J, Zhou M et al. (2013) LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One 8, e62869.
27. Dutta A, Sen T, Banerji A, Das S & Chatterjee A (2009) Studies on multifunctional effect of all-trans retinoic acid (ATRA) on matrix metalloproteinase-2 (MMP-2) and its regulatory molecules in human breast cancer cells (MCF-7). J Oncol 2009, 627840.
28. Watanabe M, Chen IY, Ishikura Y, Nakagawa T, Mochizuki M, Nishimura R, Sasaki N & Sugano S (2009) Tumor cell growth inhibition and cell differentiation analysis in a canine mammary tumor cell line (MCM-B2) treated with four chemical reagents. J Vet Med Sci 71, 1413-1417.
29. Koay DC, Zerillo C, Narayan M, Harris LN & DiGiovanna MP (2010) Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations. Breast Cancer Res 12, R62.
30. Karabulut B, Karaca B, Varol U, Muslu U, Cakar B, Atmaca H, Kisim A, Uzunoglu S & Uslu R (2010) Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer. J Exp Clin Cancer Res 29, 102.
31. Lehmann S, Paul C & Torma H (2001) Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Clin Cancer Res 7, 367-373.
32. Guidoboni M, Zancai P, Cariati R, Rizzo S, Dal Col J, Pavan A, Gloghini A, Spina M, Cuneo A, Pomponi F et al. (2005) Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Cancer Res 65, 587-595.
33. Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR & Gronemeyer H (2007) RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 6, 793-810.
34. Kitareewan S, Blumen S, Sekula D, Bissonnette RP, Lamph WW, Cui Q, Gallagher R & Dmitrovsky E (2008) G0S2 is an all-trans-retinoic acid target gene. Int J Oncol 33, 397-404.
35. Di YP, Harper R, Zhao Y, Pahlavan N, Finkbeiner W & Wu R (2003) Molecular cloning and characterization of spurt, a human novel gene that is retinoic acidinducible and encodes a secretory protein specific in upper respiratory tracts. J Biol Chem 278, 1165-1173.
36. Bingle L, Barnes FA, Cross SS, Rassl D, Wallace WA, Campos MA & Bingle CD (2007) Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis. Respir Res 8, 79.
37. Singh AT, Evens AM, Anderson RJ, Beckstead JA, Sankar N, Sassano A, Bhalla S, Yang S, Platanias LC, Forte TM et al. (2010) All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma. Br J Haematol 150, 158-169.
38. Sun SY, Wan H, Yue P, Hong WK & Lotan R (2000) Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition. J Biol Chem 275, 17149-17153.
39. Davis KD & Lazar MA (1993) Induction of retinoic acid receptor-beta by retinoic acid is cell specific. Endocrinology 132, 1469-1474.
40. Yu Z, Li W, Lu Q, Wang L, Zhang X, Han P, Chen P & Pei Y (2008) p21 is required for atRA-mediated growth inhibition of MEPM cells, which involves RAR. J Cell Biochem 104, 2185-2192.
41. Lawson ND & Berliner N (1999) Neutrophil maturation and the role of retinoic acid. Exp Hematol 27, 1355-1367.
42. Collins SJ (2002) The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 16, 1896-1905.
43. Fenaux P, Chomienne C & Degos L (2001) All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 38, 13-25.
44. Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, Tan C, Li XL, Shen SR, Zhou M et al. (2006) Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol 37, 593-605.
45. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, Huang D, Li Z, Li D, Wu M et al. (2009) Identification of aberrant cell cycle regulation in Epstein-Barr virusassociated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin (Shanghai) 41, 414-428.
46. Zhang W, Zeng Z, Fan S, Wang J, Yang J, Zhou Y, Li X, Huang D, Liang F, Wu M et al. (2012) Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. J Mol Histol 43, 297-306.
47. Zhang W, Huang C, Gong Z, Zhao Y, Tang K, Li X, Fan S, Shi L, Zhang P, Zhou Y et al. (2013) Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol 44, 545-554.
48. Guo X, Liao Q, Chen P, Li X, Xiong W, Ma J, Luo Z, Tang H, Deng M, Zheng Y et al. (2012) The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin Oncol 138, 49-56.